Search company, investor...

Predict your next investment

Investments

2

Portfolio Exits

2

About Tara Ventures

Headquarters Location

Want to inform investors similar to Tara Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Tara Ventures Investments

2 Investments

Tara Ventures has made 2 investments. Their latest investment was in Afmedica as part of their Series A on April 4, 2003.

CBI Logo

Tara Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/23/2003

Series A

Afmedica

$1.3M

Yes

2/17/1998

Private Equity

Subscribe to see more

$99M

Subscribe to see more

0

Date

4/23/2003

2/17/1998

Round

Series A

Private Equity

Company

Afmedica

Subscribe to see more

Amount

$1.3M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

0

Tara Ventures Portfolio Exits

2 Portfolio Exits

Tara Ventures has 2 portfolio exits. Their latest portfolio exit was Afmedica on October 21, 2005.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/21/2005

Acquired

$99M

5/28/1998

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/21/2005

5/28/1998

Exit

Acquired

IPO

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.